财新传媒
财新英文 > 要闻 > 正文

Cover Story: China Formally Enlists ‘Miracle’ Drug in Fight Against Ballooning Obesity Rate

By Cui Xiaotian, Jiang Moting and Denise Jia
2024年09月02日 08:50
New guidelines from a leading medical advisory body incorporating blockbuster medications such as Ozempic into more traditional weight loss treatments could change the lives of millions and bolster already soaring sales for drugmakers

Fang Xia, a 24-year-old woman, has faced a lifelong struggle with obesity, a condition that has plagued her both physically and psychologically. But like millions of others around the world, her life was turned around after taking semaglutide, a glucagon-like peptide-1 (GLP-1) analog that mimics a hormone that triggers a sense of fullness and helps overweight people shed the pounds.

  [财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]

责任编辑:Richard | 版面编辑:喻竹杨洋

图片推荐

视听推荐

财新网主编精选版电邮 样例
财新网新闻版电邮全新升级!财新网主编精心编写,每个工作日定时投递,篇篇重磅,可信可引。
订阅